MARKET

GNPX

GNPX

Genprex Inc
NASDAQ
0.3546
-0.0055
-1.53%
Opening 12:50 03/14 EDT
OPEN
0.3600
PREV CLOSE
0.3601
HIGH
0.3700
LOW
0.3465
VOLUME
544.00K
TURNOVER
--
52 WEEK HIGH
5.05
52 WEEK LOW
0.2806
MARKET CAP
3.02M
P/E (TTM)
-0.0298
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GNPX last week (0303-0307)?
Weekly Report · 4d ago
Weekly Report: what happened at GNPX last week (0224-0228)?
Weekly Report · 03/03 11:59
Weekly Report: what happened at GNPX last week (0217-0221)?
Weekly Report · 02/24 11:58
Genprex announces advancement of diabetes program, strategic collaboration
TipRanks · 02/19 13:36
enprex Announces Strategic CDMO Collaboration For Diabetes Gene Therapy Using Non-Viral Delivery System
Benzinga · 02/19 13:16
GENPREX ADVANCES DIABETES PROGRAM WITH ADDITION OF RESEARCH FOCUSED ON NON-VIRAL DELIVERY SYSTEM
Reuters · 02/19 13:15
Genprex Strengthens Diabetes Focus with New License
TipRanks · 02/18 13:49
Genprex announces advancement of its diabetes gene therapy program
TipRanks · 02/18 13:20
More
About GNPX
More
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Company’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid nanoparticles. The Company’s lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Using a different gene therapy delivery system, the Company is also developing its preclinical diabetes candidate GPX-002 using the same construct for both Type 1 diabetes and Type 2 diabetes. It conducts preclinical research to explore how REQORSA may be administered in other solid tumors.
Recently
Symbol
Price
%Change

Webull offers Genprex Inc stock information, including NASDAQ: GNPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNPX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNPX stock methods without spending real money on the virtual paper trading platform.